Metabolic progression to clinical phenotype in classic Fabry disease

BACKGROUND: Fabry disease is an X-linked lysosomal storage disorder due to α-galactosidase A (α-Gal A) deficiency. Clinical onset of Fabry disease is preceded by significant storage of globotriaosylceramide (Gb3) and related glycosphingolipids, but the extent of the metabolic progression before symp...

Descripción completa

Detalles Bibliográficos
Autores principales: Spada, Marco, Kasper, David, Pagliardini, Veronica, Biamino, Elisa, Giachero, Silvana, Porta, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5209809/
https://www.ncbi.nlm.nih.gov/pubmed/28049500
http://dx.doi.org/10.1186/s13052-016-0320-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5209809/
https://www.ncbi.nlm.nih.gov/pubmed/28049500
http://dx.doi.org/10.1186/s13052-016-0320-1

Ejemplares similares